ReviewFrontiers in oncology2024

Research progress on the role of bypass activation mechanisms in resistance to tyrosine kinase inhibitors in non-small cell lung cancer.

Ziyang Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.